Molecular Epidemiology of Clostridioides difficile Infections in Children

Sicilia Perumalsamy1, Thomas V Riley1,2,3,4

  • 1The University of Western Australia, School of Biomedical Sciences, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.

Insights

Pediatric Clostridioides difficile infection (CDI) is rising, yet its molecular epidemiology remains poorly understood. This review highlights the need for more research into specific C. difficile strains affecting children.

Area of Science:

  • Microbiology
  • Pediatric Gastroenterology
  • Infectious Diseases

Background:

  • Clostridioides difficile infection (CDI) is a significant cause of healthcare-associated gastrointestinal illness.
  • Research on pediatric CDI has historically lagged behind adult studies.
  • Recent data indicate increasing CDI incidence in children, including those in the community and with comorbidities like inflammatory bowel disease and hematological malignancies.

Purpose of the Study:

  • To review the current understanding of the molecular epidemiology of pediatric Clostridioides difficile infection.
  • To identify knowledge gaps in pediatric CDI strain characterization.
  • To summarize available information on C. difficile strains implicated in childhood infections.

Main Methods:

  • Literature review of studies on pediatric Clostridioides difficile infection.
  • Analysis of reported C. difficile strains and their prevalence in children.
  • Synthesis of data on molecular typing and epidemiology of pediatric CDI.

Main Results:

  • Pediatric CDI encompasses a spectrum of gastrointestinal diseases, from mild diarrhea to severe conditions.
  • Rising CDI rates in children are observed globally, with increasing reports in community settings.
  • Challenges exist in differentiating colonization from infection, complicating treatment decisions.
  • The molecular epidemiology of pediatric CDI is not well-understood, despite identification of some hypervirulent strains (e.g., ribotypes 027, 078).

Conclusions:

  • Further research is crucial to elucidate the molecular epidemiology of pediatric CDI.
  • Understanding specific C. difficile strains in children is essential for effective diagnosis and management.
  • Addressing knowledge gaps will improve the care of children with CDI.